Details for New Drug Application (NDA): 060593
✉ Email this page to a colleague
NDA 060593 describes SEROMYCIN, which is a drug marketed by Sanaluz and is included in one NDA. It is available from one supplier. Additional details are available on the SEROMYCIN profile page.
The generic ingredient in SEROMYCIN is cycloserine. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cycloserine profile page.
The generic ingredient in SEROMYCIN is cycloserine. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cycloserine profile page.
Summary for 060593
| Tradename: | SEROMYCIN |
| Applicant: | Sanaluz |
| Ingredient: | cycloserine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 060593
Suppliers and Packaging for NDA: 060593
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| SEROMYCIN | cycloserine | CAPSULE;ORAL | 060593 | ANDA | Dr. Reddy?s Laboratories, Inc. | 43598-235 | 43598-235-31 | 3 BLISTER PACK in 1 CARTON (43598-235-31) / 10 CAPSULE in 1 BLISTER PACK (43598-235-10) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 250MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
